Some studies have shown that increased levels of inflammatory markers, mainly interleukin-6 (IL-6) and C-reactive protein (CRP), are associated with an increased risk of perioperative complications and mortality in surgical patients [24,25,26], with limited benefit from percutaneous coronary intervention (PCI) in patients with CAD [27]. Here, IL6 is linked to coronary artery disorder.